The rising prevalence in GLP-1 agonists for weight loss has led to a question about formats: transdermal systems versus capsules. Traditionally , GLP-1 treatments were exclusively available in pill form, but the introduction of skin applications presents a new choice . Skin applications might be advantageous for individuals with challenges taking p